Precigen (PGEN) Divestments (2018 - 2022)
Precigen's (PGEN) quarterly Divestments came in at $936000.0 in Q4 2022, down 98.54% on a QoQ basis from $64.2 million in Q1 2020.
Precigen (PGEN) Divestments (2018 - 2022) Analysis & Trends
Precigen (PGEN) has 4 years of Divestments data on file, last reported at $936000.0 in Q4 2022.
- On a quarterly basis, Divestments changed N/A year-over-year to $936000.0 in Q4 2022; TTM through Dec 2023 was $936000.0, a 0.0% change from a year earlier, with the FY2022 full-year figure at $162.3 million, changed N/A from the prior year.
- Divestments for Q4 2022 stood at $936000.0, down from $64.2 million in the prior quarter.
- Over the last five years, Divestments for PGEN reached as high as $64.2 million in Q1 2020 and fell as low as -$125000.0 in Q4 2019.
- Historically, Divestments has averaged $13.6 million across 4 years, with a median of $936000.0 in 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 936,000.00 |
| Mar 31, 2020 | 64.24 Mn |
| Dec 31, 2019 | -125,000.00 |
| Sep 30, 2019 | 125,000.00 |
| Mar 31, 2018 | 2.60 Mn |